摘要
一些流行病学研究结果表明:在未来几十年里糖尿病会成为全球流行病,在2030年全球将会有超过4亿的糖尿病患者。大多数患者为2型糖尿病(T2DM),其扩散主要与过度卡路里上传、久坐不动的生活和肥胖有关。通常,T2DM的治疗是节食、控制体重,身体活动或降糖和/或降脂药物。不幸的是,这些药物通常低效或副作用,从而迫使患者停止药物治疗。然而传统医学建议使用一些配方或药用食物来治疗2型糖尿病。它们中大多数的特点是安全、低成本、有效和良好可用性。现代药理学出现之前,这些疗法用于治疗糖尿病和肥胖或防止其发生。今天,我们知道它们的有效性归因于一些能够影响胰岛素信号通路和细胞代谢的活性化合物的存在。在过去的几十年里,进行了很多努力来探明它们的作用机制。在此我们提供了一个刺激胰岛素信号通路的天然化合物的分类,强调其在控制糖尿病动物模型的血糖过多或改善细胞胰岛素信号中的有效性。
关键词: AMPK,胰岛素信号,天然化合物,PPAR,PTP1B抑制剂,2型糖尿病。
Current Medicinal Chemistry
Title:Effect of Natural Compounds on Insulin Signaling
Volume: 22 Issue: 1
Author(s): Paolo Paoli, Anna Caselli, Guido Camici and Paolo Cirri
Affiliation:
关键词: AMPK,胰岛素信号,天然化合物,PPAR,PTP1B抑制剂,2型糖尿病。
摘要: Results of several epidemiological studies have indicated that diabetes mellitus will become a global epidemic in the next decades, being more than 400 million the human subjects in the world affected by this disease in the 2030. Most of these subjects will be affected by type 2 diabetes mellitus (T2DM) whose diffusion is mainly related to excessive caloric upload, sedentary life and obesity. Typically, the treatment for T2DM is diet, weight control, physical activity or hypoglycaemic and/or lipid-lowering drugs. Unfortunately, these drugs often show low effectiveness or adverse side effects, thereby forcing patient to discontinue medical treatment. Nevertheless traditional medicine suggests the use of several formulations or medicinal foods to treat T2DM. Most of them are characterized by safety, low cost, effectiveness, and good availability. Before the advent of modern pharmacology, these remedies were used to treat diabetes and obesity or prevent their onset. Today, we know that their effectiveness is due to the presence of several bioactive compounds able to influence insulin signaling pathway and cellular metabolism. In the last decades, many efforts have been carried out to clarify their action mechanism. Here we provide a classification of the natural compounds that stimulate the insulin pathway, highlighting their effectiveness in controlling glycaemia on diabetic animal models or improving insulin signaling in cellular systems.
Export Options
About this article
Cite this article as:
Paolo Paoli, Anna Caselli, Guido Camici and Cirri Paolo, Effect of Natural Compounds on Insulin Signaling, Current Medicinal Chemistry 2015; 22 (1) . https://dx.doi.org/10.2174/0929867321666140815123249
DOI https://dx.doi.org/10.2174/0929867321666140815123249 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020)
Current Medicinal Chemistry Design of Bioartificial Pancreas with Functional Micro/Nano-Based Encapsulation of Islets
Current Pharmaceutical Biotechnology Stress, Cardiovascular Diseases and Surgery-Induced Angiogenesis
Current Angiogenesis (Discontinued) Bacterial Protein Toxins: Current and Potential Clinical Use
Current Medicinal Chemistry Progesterone/Progestagens to Prevent Preterm Birth: When and How
Current Women`s Health Reviews Nutrigenomic Analysis of Diet-Gene Interactions on Functional Supplements for Weight Management
Current Genomics Asymptomatic Primary Hyperparathyroidism: Management and Implications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study
Current Alzheimer Research Microvascular Alterations in Hypertension and Vascular Aging
Current Hypertension Reviews Antidiabetic Drugs and the Kidney
Current Pharmaceutical Design Exploring AT2R and its Polymorphism in Different Diseases: An Approach to Develop AT2R as a Drug Target beyond Hypertension
Current Drug Targets Pleiotropic Effects of Omega-3 Fatty Acids
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
Current Medicinal Chemistry A proteomics based approach for the identification of gastric cancer related markers
Current Pharmaceutical Design Biomarkers of Oxidative Stress and the Relationship to Cigarette Smoking
Mini-Reviews in Organic Chemistry Current Therapeutic Concepts in Peripartum Cardiomyopathy
Current Pharmaceutical Design An Overview of the Current and Novel Drugs for Alzheimers Disease with Particular Reference to Anti-Cholinesterase Compounds
Current Pharmaceutical Design Exercise and Postprandial Glycemic Control in Type 2 Diabetes
Current Diabetes Reviews Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Inflammation & Allergy - Drug Targets (Discontinued) Glucose and LDL Lowering: The Need for Intensive Therapy
Current Vascular Pharmacology